Zobrazeno 1 - 10
of 44
pro vyhledávání: '"M. M. Urist"'
Autor:
M. M. Urist, C. M. Balch
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 108:1008-1013
The action of floxuridine depends greatly on its concentration for treatment of liver metastases of colorectal carcinomas and other tumors. In isolated liver metastases it is best infused regionally in order to achieve a high concentration and to red
Autor:
E, Rubin, S T, Mennemeyer, R A, Desmond, M M, Urist, J, Waterbor, M J, Heslin, W K, Bernreuter, P J, Dempsey, N S, Pile, W H, Rodgers
Publikováno v:
Cancer. 91(2)
The objective of this study was to determine whether the use of ultrasound and percutaneous breast biopsies in patients with screen-detected nonpalpable abnormalities can reduce benign open surgical biopsies of the breast without increasing cost or s
Publikováno v:
The American surgeon. 66(12)
Gastrointestinal (GI) sarcomas are uncommon tumors with the majority of previous studies performed over long time intervals. The purpose of this review is to analyze our single-institution experience with primary GI sarcomas. Between January 1990 and
Autor:
C M, Balch, S, Soong, M I, Ross, M M, Urist, C P, Karakousis, W J, Temple, M C, Mihm, R L, Barnhill, W R, Jewell, H J, Wanebo, R, Harrison
Publikováno v:
Annals of surgical oncology. 7(2)
Ten- to 15-year survival results were analyzed from a prospective multi-institutional randomized surgical trial that involved 740 stages I and II melanoma patients with intermediate thickness melanomas (1.0 to 4.0 mm) and compared elective (immediate
Publikováno v:
Headneck. 21(2)
The management of micrometastatic disease from squamous cell carcinoma (SCC) of the oral tongue remains controversial. This study describes prognostic factors in the disease and reviews the role of elective neck dissection (END).A retrospective analy
Publikováno v:
Journal of clinical epidemiology. 51(10)
The controversy over whether melanoma of the foot has a poorer prognosis than melanoma of the leg remains unresolved. This investigation used a case-control design to address this issue. This design consisted of a survival analysis of 119 cases with
Publikováno v:
Journal of surgical oncology. 67(4)
Approximately one third of all melanoma patients will experience disease recurrence. Factors that affect patient survival following local, regional, or distant first recurrences of localized melanoma are the subject of this investigation.Survival tim
Publikováno v:
Cancer. 79(6)
Over the past 2 decades, remarkable progress has been made in the identification of clinical and pathologic factors that affect the survival of patients with melanoma. Through the use of multivariate regression methods, key prognostic factors, such a
Publikováno v:
Advances in surgery. 28
Autor:
M K, Wallack, M, Sivanandham, C M, Balch, M M, Urist, K I, Bland, D, Murray, W A, Robinson, L E, Flaherty, J M, Richards, A A, Bartolucci
Publikováno v:
Cancer. 75(1)
In a Phase II trial, surgical adjuvant active specific immunotherapy using a live vaccinia virus-augmented allogeneic polyvalent melanoma cell lysate, vaccinia melanoma oncolysate (VMO), produced a significant disease free interval (DFI) in patients